Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01928186
What this trial is testing

FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeMale Breast Carcinoma+7 more
University of Washington 28
Post-approval studies (Phase 4)Study completedNCT00227942
What this trial is testing

Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia

Who this might be right for
Sleep Initiation and Maintenance DisordersDepression
Hadine Joffe, MD 86
Testing effectiveness (Phase 2)Study completedNCT01997333
What this trial is testing

Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer

Who this might be right for
Metastatic gpNMB Over-expressing Triple Negative Breast Cancer
Celldex Therapeutics 327
Not applicableLooking for participantsNCT04476485
What this trial is testing

Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy

Who this might be right for
Breast Cancer
Shengjing Hospital 1,000
Testing effectiveness (Phase 2)UnknownNCT05133674
What this trial is testing

Therapeutic Dose Monitoring (TDM) of Tamoxifen

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+2 more
Karolinska University Hospital 40
Post-approval studies (Phase 4)Study completedNCT00252408
What this trial is testing

Danish Osteoporosis Prevention Study

Who this might be right for
Osteoporosis
University of Aarhus 2,000
Testing effectiveness (Phase 2)Study completedNCT00586898
What this trial is testing

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Who this might be right for
ProstateCancerHormonal Cycling
Memorial Sloan Kettering Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT01616758
What this trial is testing

Phase II Study of GTx024 in Women With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
GTx 22
Large-scale testing (Phase 3)UnknownNCT00887380
What this trial is testing

STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing)

Who this might be right for
Breast Cancer
Trans Tasman Radiation Oncology Group 2,023
Large-scale testing (Phase 3)Study completedNCT04629846
What this trial is testing

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive and Estrogen Receptor/Progesterone Receptor Negative Breast Cancer to Evaluate the Efficiency and Safety of Treatment With Trastuzumab Plus (+) QL1209/Pertuzumab + Docetaxel.

Who this might be right for
Breast Cancer
Qilu Pharmaceutical Co., Ltd. 517
Large-scale testing (Phase 3)Looking for participantsNCT06530459
What this trial is testing

The MUSE Study for Menopausal Arthralgia

Who this might be right for
ArthralgiaMenopausePerimenopausal Disorder+2 more
National University Hospital, Singapore 100
Testing effectiveness (Phase 2)Ended earlyNCT00661531
What this trial is testing

Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy

Who this might be right for
Breast CancerCancer of the BreastNeoplasms, Breast
Georgetown University 11
Very early researchStudy completedNCT03599453
What this trial is testing

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple -Negative Breast CancerEstrogen Receptor NegativeHER2/Neu Negative+2 more
Roswell Park Cancer Institute 8
Large-scale testing (Phase 3)Study completedNCT00687102
What this trial is testing

Cognition in the Study of Tamoxifen and Raloxifene

Who this might be right for
CognitionAging
Wake Forest University 1,498
Testing effectiveness (Phase 2)Ended earlyNCT03284957
What this trial is testing

Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 136
Not applicableStudy completedNCT03437837
What this trial is testing

Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China

Who this might be right for
Breast CancerNeoadjuvant TherapyNeoplasm Staging+5 more
Peking University First Hospital 1,077
Testing effectiveness (Phase 2)WithdrawnNCT01895881
What this trial is testing

Estrogen Therapy as Prevention in the Progression of Aneurysm (EPPA) Trial

Who this might be right for
Cerebral AneurysmMenopauseTreatment
Rush University Medical Center
Testing effectiveness (Phase 2)Study completedNCT03870399
What this trial is testing

Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression

Who this might be right for
Neuroendocrine TumorsProgesterone Receptor Positive TumorEstrogen Receptor Positive Tumor
AC Camargo Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT00331214
What this trial is testing

Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Who this might be right for
Hypoactive Sexual Desire Disorder
Warner Chilcott 533
Testing effectiveness (Phase 2)Looking for participantsNCT05716516
What this trial is testing

STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)

Who this might be right for
Metastatic Breast Cancer
Dartmouth-Hitchcock Medical Center 36
Next Page